Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Belinda Headon

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Gastroenterology and Hepatology|March 19, 2016
How to manage the logistics of biological therapyBelinda Headon
Australian Family Physician|April 7, 2010
Update in inflammatory bowel diseaseGraham Morrison, Belinda Headon, Peter Gibson
Journal of Crohn'S & Colitis|November 10, 2017
Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot StudyLauren Beswick, Ourania Rosella, Gennaro Rosella, et al.
Therapeutic Drug Monitoring|September 29, 2022
Pharmacist-Driven Therapeutic Infliximab Monitoring at the Point of Care Using Rapidly Assessed Drug Levels in Patients with Inflammatory Bowel DiseaseClarissa A Rentsch, Mark G Ward, Raphael P Luber, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Gastroenterology and Hepatology|March 19, 2016
How to manage the logistics of biological therapyBelinda Headon
Australian Family Physician|April 7, 2010
Update in inflammatory bowel diseaseGraham Morrison, Belinda Headon, Peter Gibson
Journal of Crohn'S & Colitis|November 10, 2017
Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot StudyLauren Beswick, Ourania Rosella, Gennaro Rosella, et al.
Therapeutic Drug Monitoring|September 29, 2022
Pharmacist-Driven Therapeutic Infliximab Monitoring at the Point of Care Using Rapidly Assessed Drug Levels in Patients with Inflammatory Bowel DiseaseClarissa A Rentsch, Mark G Ward, Raphael P Luber, et al.
Pageof 1